Perfect ALKemy: Optimizing the Use of ALK-Directed Therapies in Lung Cancer

Tekijä Politi, Katerina, Gettinger, Scott
Julkaisussa Clin Cancer Res (2014)

PD-1 axis inhibitors in EGFR and ALK Driven Lung Cancer: Lost cause?

Tekijä Gettinger, Scott, Politi, Katerina
Julkaisussa Clin Cancer Res (2016)

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer

Tekijä Flanigan, Jaclyn, Deshpande, Hari, Gettinger, Scott
Julkaistu 2010

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Tekijä Deshpande, Hari A, Gettinger, Scott, Sosa, Julie Ann
Julkaistu 2010

Immuno-thermal ablations – boosting the anticancer immune response

Tekijä Slovak, Ryan, Ludwig, Johannes M., Gettinger, Scott N., Herbst, Roy S., Kim, Hyun S.
Julkaisussa J Immunother Cancer (2017)

Late recurrence of basaloid carcinoma initially treated as a small cell lung cancer

Tekijä Shumaster, Vladimir, Bae, Jason W., Gettinger, Scott N., Cai, Guoping, Kim, Anthony W.
Julkaistu 2013

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

Tekijä Dhodapkar, Kavita M, Gettinger, Scott N, Das, Rituparna, Zebroski, Henry, Dhodapkar, Madhav V
Julkaistu 2013

Oncolytic virus immunotherapy: future prospects for oncology

Tekijä Raja, Junaid, Ludwig, Johannes M., Gettinger, Scott N., Schalper, Kurt A., Kim, Hyun S.
Julkaisussa J Immunother Cancer (2018)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy

Tekijä Hughes, Jing, Vudattu, Nalini, Sznol, Mario, Gettinger, Scott, Kluger, Harriet, Lupsa, Beatrice, Herold, Kevan C.
Julkaisussa Diabetes Care (2015)

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

Tekijä Adam, Lucas C., Raja, Junaid, Ludwig, Johannes M., Adeniran, Adebowale, Gettinger, Scott N., Kim, Hyun S.
Julkaisussa J Immunother Cancer (2018)

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer

Tekijä Dhodapkar, Kavita, Verma, Rakesh, Sznol, Mario, Boddupalli, Chandra Sekhar, Gettinger, Scott, Kluger, Harriet, Dhodapkar, Madhav, Das, Rituparna
Julkaisussa J Immunother Cancer (2014)

An Advanced Practice Nurse Coordinated Multidisciplinary Intervention for Patients with Late-Stage Cancer: A Cluster Randomized Trial

Tekijä McCorkle, Ruth, Jeon, Sangchoon, Ercolano, Elizabeth, Lazenby, Mark, Reid, Amanda, Davies, Marianne, Viveiros, Diane, Gettinger, Scott
Julkaisussa J Palliat Med (2015)

Preliminary safety, pharmacokinetics, and efficacy of regorafenib, cisplatin, and pemetrexed in patients with advanced non-squamous non-small cell lung cancers

Tekijä Hellmann, Matthew D, Sturm, Isrid, Trnkova, Zuzana Jirakova, Lettieri, John, Diefenbach, Konstanze, Rizvi, Naiyer A., Gettinger, Scott N.
Julkaisussa Clin Lung Cancer (2015)

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Tekijä Carvajal-Hausdorf, Daniel, Altan, Mehmet, Velcheti, Vamsidhar, Gettinger, Scott N., Herbst, Roy S., Rimm, David L., Schalper, Kurt A.
Julkaisussa J Immunother Cancer (2019)

Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer

Tekijä Uhlig, Johannes, Case, Meaghan Dendy, Blasberg, Justin D., Boffa, Daniel J., Chiang, Anne, Gettinger, Scott N., Kim, Hyun S.
Julkaisussa JAMA Netw Open (2019)

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

Tekijä Zugazagoitia, Jon, Gupta, Swati, Liu, Yuting, Fuhrman, Kit, Gettinger, Scott, Herbst, Roy, Schalper, Kurt A., Rimm, David L.
Julkaisussa Clin Cancer Res (2020)

High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas

Tekijä Velcheti, Vamsidhar, Schalper, Kurt, Yao, Xiaopan, Cheng, Huan, Kocoglu, Mehmet, Dhodapkar, Kavita, Deng, Yanhong, Gettinger, Scott, Rimm, David L.
Julkaistu 2013

Treatment of Stage IV Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Tekijä Socinski, Mark A., Evans, Tracey, Gettinger, Scott, Hensing, Thomas A., VanDam Sequist, Lecia, Ireland, Belinda, Stinchcombe, Thomas E.
Julkaisussa Chest (2013)

Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy

Tekijä Suozzi, Kathleen C., Stahl, Maximilian, Ko, Christine J., Chiang, Anne, Gettinger, Scott N., Siegel, Mark D., Bunick, Christopher G.
Julkaisussa JAAD Case Rep (2016)

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

Tekijä Shi, Veronica J., Rodic, Nemanja, Gettinger, Scott, Leventhal, Jonathan S., Neckman, Julia P., Girardi, Michael, Bosenberg, Marcus, Choi, Jennifer N.
Julkaisussa JAMA Dermatol (2016)